PIK3R1, Akt1, and Rheb1 have been identified as important components of PI3K/Akt signaling activation, and they have been suggested as therapeutic targets in lung cancer treatment [12, 30, 31]. The gene discussed is RHEBP1; the disease is lung carcinoma.